{
    "clinical_study": {
        "@rank": "144584", 
        "arm_group": [
            {
                "arm_group_label": "AdVance", 
                "arm_group_type": "Active Comparator", 
                "description": "sling procedure"
            }, 
            {
                "arm_group_label": "ARGUS", 
                "arm_group_type": "Active Comparator", 
                "description": "sling procedure"
            }
        ], 
        "brief_summary": {
            "textblock": "The study is designed to assess efficacy and subject satisfaction of two sling devices:\n      Advance and Argus, in male patients with stress urinary incontinence after prostatectomy."
        }, 
        "brief_title": "AdVance\u00ae vs ARGUS\u00ae Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Stress Urinary Incontinence", 
        "condition_browse": {
            "mesh_term": [
                "Urinary Incontinence", 
                "Urinary Incontinence, Stress"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The subject is male\n\n          -  The subject is at least 18 years of age\n\n          -  The subject has an estimated life expectancy of more than 5 years\n\n          -  The subject has confirmed stress urinary incontinence (SUI) through medical history,\n             urodynamics, and/or physical exam for at least 6 months\n\n          -  The subject has intrinsic sphincter deficiency due to one of the following:\n\n        post-TURP, simple open prostatectomy, radical prostatectomy completed at least 6 months\n        prior to implantation date\n\n          -  Positive Cough Stress Test (CST):\n\n          -  Positive 24-hours Pad Test (PT):\n\n        A positive PT is confirmed with leakage of >8.O g/24h and < 400 g\n\n          -  The subject has completed urodynamics, uroflow, post-void residual, and cystoscopy as\n             per the protocol within 6 months prior to implant\n\n          -  The subject is able and willing to complete all follow-up visits and procedures\n             indicated in this protocol\n\n          -  The subject has been informed of the nature of the study and agrees to its provisions\n             and has provided written informed consent as approved by the local ethics commit-tee\n             of the respective site\n\n        Exclusion Criteria:\n\n          -  Subjects who meet any of the following criteria are excluded from entry into the\n             study\n\n          -  The subject is unable or unwilling to sign the Informed Consent Form (ICF) and/or\n             comply with all follow-up requirements according to the study protocol\n\n          -  The subject has an active urogenital infection or active skin infection in region of\n             surgery\n\n          -  The subject has serious bleeding disorders\n\n          -  The subject has incontinence due to neurogenic causes defined as multiple sclerosis,\n             spinal cord/brain injury, CVA, detrusor-external sphincter dyssynergia, Parkinson's\n             disease, or similar conditions\n\n          -  The subject had a previous implant to treat stress urinary incontinence\n\n          -  The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate\n             or other pelvic cancer within 6 months\n\n          -  The subject is likely to undergo radiation therapy within the next 6 months\n\n          -  The subject has active urethral or bladder neck stricture disease, requiring\n             continued treatment\n\n          -  The subject has urge predominant incontinence\n\n          -  The subject has an atonic bladder or a postvoid residual (PVR) \u2265150mL\n\n          -  The subject has a condition or disorder likely to require future transurethral\n             procedure\n\n          -  The subject is enrolled in a concurrent clinical trial of any treatment (drug or\n             device) that could affect continence function without the sponsors'approval\n\n          -  Subjects who in the opinion of the investigator are unable and/or unlikely to to\n             comprehend the nature, scope and possible consequences of the study and to follow the\n             study procedures and instructions and complete all study related measurements."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01866085", 
            "org_study_id": "12-013", 
            "secondary_id": "12-013"
        }, 
        "intervention": [
            {
                "arm_group_label": "AdVance", 
                "intervention_name": "AdVance\u00ae  sling procedure", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "ARGUS", 
                "intervention_name": "ARGUS Sling procedure", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "stress urinary incontinence", 
            "post prostatectomy"
        ], 
        "lastchanged_date": "May 30, 2013", 
        "location": {
            "contact": {
                "email": "jcorcos@jgh.mcgill.ca", 
                "last_name": "Jacques Corcos, MD", 
                "phone": "1-514-340-8222", 
                "phone_ext": "5166"
            }, 
            "contact_backup": {
                "email": "oloutochin@jgh.mcgill.ca", 
                "phone": "1-514-340-8222", 
                "phone_ext": "1627"
            }, 
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H3T 1E2"
                }, 
                "name": "Jewish General Hospital"
            }, 
            "investigator": {
                "last_name": "Jacques Corcos, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomised Clinical Trial to Evaluate Efficacy of AdVance\u00ae vs ARGUS\u00ae Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence", 
        "other_outcome": {
            "measure": "Summarize all cumulative device and procedure related adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "overall_contact": {
            "email": "jcorcos@jgh.mcgill.ca", 
            "last_name": "Jacques Corcos, MD", 
            "phone": "1-514-340-8222", 
            "phone_ext": "5166"
        }, 
        "overall_contact_backup": {
            "email": "oloutochin@jgh.mcgill.ca", 
            "last_name": "Oleg Loutochin", 
            "phone": "1-514-340-8222", 
            "phone_ext": "1627"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Patient satisfaction using the Patient Global Impression of Improvement (PGI-I) score and assess change in 24-hour pad weight .", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01866085"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Jewish General Hospital", 
            "investigator_full_name": "Jacques Corcos", 
            "investigator_title": "MD.  Professor of Urology, McGill University", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Assess change in subject satisfaction using questionnaires: ICIQ, UCLA-RAND Incontinence Index.", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Jewish General Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Center Hospitalier de Fleurimont,Sherbrooke University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Sunnybrook Health Sciences Centre", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Jewish General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}